| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.69M | - | |
| Other | 52.8K | $8.53M | - | |
| Other | 46.8K | $7.56M | - | |
| Other | 39.6K | $6.41M | -36,937 | |
| Other | 36.8K | $5.96M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Rastetter William H48 | Director | Sale+OE | 11,044 | $131.47 | $1,451,927.07 | -17.6% | +7.3% | +4.7% | |
| Dec 22, 2023 | Roberts Eiry49 | Chief Medical Officer | Sell | 10,000 | $126.74 | $1,267,448.00 | -33.9% | +11.9% | +5.4% | |
| Dec 22, 2023 | Lyons Gary A54 | Director | Sell | 10,000 | $130.04 | $1,300,443.00 | -4.9% | +11.9% | +5.4% | |
| Dec 22, 2023 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 24,000 | $128.66 | $3,087,807.80 | -41.0% | +11.9% | +5.4% | |
| Dec 12, 2023 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 13,925 | $120.30 | $1,675,240.06 | -19.1% | +13.9% | +5.4% | |
| Dec 8, 2023 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 77,679 | $120.37 | $9,350,350.23 | -30.5% | +15.4% | +9.3% | |
| Dec 6, 2023 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 8,396 | $120.03 | $1,007,780.28 | -22.1% | +11.9% | +5.8% | |
| Dec 6, 2023 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 20,830 | $119.86 | $2,496,648.39 | -36.7% | +11.9% | +5.8% | |
| Dec 1, 2023 | Lyons Gary A54 | Director | Sale+OE | 5,000 | $116.77 | $583,837.00 | -2.4% | +11.3% | +8.2% | |
| Nov 29, 2023 | Onyia Jude54 | Chief Scientific Officer | Sell | 2,331 | $113.57 | $264,732.84 | -16.6% | +19.8% | +11.6% |